- Pelton SI. Meningococcal disease awareness: clinical and epidemiological factors affecting prevention and management in adolescents. J Adolesc Health. 2010;46:S9-S15.
- McNamara LA, Blain A. Meningococcal disease. In: Roush SW, Baldy LM, Hall MAK, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. National Center for Immunization and Respiratory Diseases. Reviewed January 5, 2022. Accessed March 29, 2022. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html
- Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.
- Slack R, Hawkins KC, Gilhooley L, Addison GM, Lewis MA, Webb NJA. Long-term outcome of meningococcal sepsis-associated acute renal failure. Pediatr Crit Care Med. 2005;6(4):477-479.
- Vyse A, Anonychuk A, Jäkel A, et al. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11(6):597-604.
- Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Reports, 2015-2019. Reviewed February 7, 2022. Accessed March 29, 2022. https://www.cdc.gov/meningococcal/surveillance/index.html#enhanced-reports
- Pingali C, Yankey D, Elam-Evans LD, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2020. MMWR. 2020;69(33):1109-1116.
- Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR. 2020;69(RR-9):1-41.
- Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022. Reviewed February 17, 2022. Accessed February 28, 2022. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html